IL-1β Promotes Expansion of IL-33+ Lung Epithelial Stem Cells after Respiratory Syncytial Virus Infection during Infancy

Am J Respir Cell Mol Biol. 2022 Mar;66(3):312-322. doi: 10.1165/rcmb.2021-0313OC.

Abstract

Respiratory syncytial virus (RSV)-induced immunopathogenesis and disease severity in neonatal mice and human infants have been related to elevated pulmonary IL-33. Thus, targeting IL-33 has been suggested as a potential therapy for respiratory viral infections. Yet, the regulatory mechanisms on IL-33 during early life remain unclear. Here, using a neonatal mouse model of RSV, we demonstrate that IL-1β positively regulates but is not required for RSV-induced expression of pulmonary IL-33 in neonatal mice early after the initial infection. Exogenous IL-1β upregulates RSV-induced IL-33 expression by promoting the proliferation of IL-33+ lung epithelial stem/progenitor cells. These cells are exclusively detected in RSV-infected neonatal rather than adult mice, partially explaining the IL-1β-independent IL-33 expression in RSV-infected adult mice. Furthermore, IL-1β aggravates IL-33-mediated T-helper cell type 2-biased immunopathogenesis upon reinfection. Collectively, our study demonstrates that IL-1β exacerbates IL-33-mediated RSV immunopathogenesis by promoting the proliferation of IL-33+ epithelial stem/progenitor cells in early life.

Keywords: IL-1β; IL-33; age-dependent RSV immunopathogenesis; epithelial stem or progenitor cells; respiratory syncytial virus.

MeSH terms

  • Animals
  • Humans
  • Interleukin-1beta / pharmacology*
  • Interleukin-33
  • Lung / pathology
  • Mice
  • Mice, Inbred BALB C
  • Respiratory Syncytial Virus Infections* / pathology
  • Respiratory Syncytial Virus, Human*
  • Stem Cells / pathology

Substances

  • Interleukin-1beta
  • Interleukin-33